Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH)
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a biopharmaceutical company focused on developing and commercializing novel therapies for infectious diseases, particularly those caused by antibiotic-resistant bacteria. The company aims to address unmet medical needs through innovative drug discovery and development, leveraging its proprietary platform technologies.
Company News
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) announced the closing of a $5.75 million underwritten public offering. The company plans to use the proceeds to fund its Phase II clinical trial, marketing, and general corporate purposes.
Shuttle Pharmaceuticals has successfully dosed the first three patients in its Phase 2 clinical trial of Ropidoxuridine for the treatment of glioblastoma, a deadly brain cancer. The company has also finalized agreements with six clinical trial sites and raised additional funding to support the trial.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has announced promising results from a study on a new compound, SP-1-303, which shows potential in inhibiting the growth of estrogen receptor positive breast cancer cells. The compound has been found to activate the ATM protein and modulate estrogen receptor expression, with the ability to sensitize cancer cells to radiation therapy and protect normal tissues.
Use these tips to maximize penny stocks trading on a budget The post Trading Penny Stocks on a Budget, Maximizing Returns appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The stock, after dropping big-time following its IPO last week, had a successful run-up this week.